Influence of adrenal subclinical hypercortisolism on hypertension in patients with adrenal incidentaloma

Experimental and Clinical Endocrinology and Diabetes

Volumn 120, Issue 4, 2012, Pages 244-247

  Oki, K ^a   Yamane, K ^a   Nakanishi, S ^a   Shiwa, T ^a   Kohno, N ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

adrenal tumor; cortisol; hypertension; subclinical Cushing's syndrome

Indexed keywords

ALDOSTERONE; RENIN;

ADRENAL CORTEX ADENOMA; ADRENAL INCIDENTALOMA; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CUSHING SYNDROME; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERCORTISOLISM; HYPERTENSION; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SMOKING; SUBCLINICAL CUSHING SYNDROME; SUBCLINICAL HYPERCORTISOLISM;

ADRENAL GLAND NEOPLASMS; ADRENOCORTICAL HYPERFUNCTION; ADULT; AGED; AGED, 80 AND OVER; ASYMPTOMATIC DISEASES; CUSHING SYNDROME; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE;

EID: 84860234454     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0032-1301896     Document Type: Article

References (24)

1. Barzon L, Sonino N, Fallo F et al. Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol: 2003; 149 273 285 (Pubitemid 37304697)
2. Catargi B, Rigalleau V, Poussin A et al. Occult Cushing's syndrome in type-2 diabetes. J Clin Endocrinol Metab: 2003; 88 5808 5813 (Pubitemid 38033055)
3. Chiodini I. Clinical review: Diagnosis and treatment of subclinical hypercortisolism. J Clin Endocrinol Metab: 2011; 96 1223 1136
4. Chiodini I, Di Lembo S, Morelli V et al. Hypothalamic-pituitary-adrenal activity in type 2 diabetes mellitus: role of autonomic imbalance. Metabolism: 2006; 55 1135 1140 (Pubitemid 44043144)
5. Chiodini I, Torlontano M, Scillitani A et al. Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients. Eur J Endocrinol: 2005; 153 837 844 (Pubitemid 43020234)
6. Crapo L. Cushing's syndrome: a review of diagnostic tests. Metabolism: 1979; 28 955 977 (Pubitemid 9256926)
7. Erbil Y, Ademolu E, Ozbey N et al. Evaluation of the cardiovascular risk in patients with subclinical Cushing syndrome before and after surgery. World J Surg: 2006; 30 1665 1671 (Pubitemid 44411221)
8. Hamm L L, Hering-Smith K S. Pivotal role of the kidney in hypertension. Am J Med Sci: 2010; 340 30 32
9. Kubo M, Kiyohara Y, Kato I et al. Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: the Hisayama study. Stroke: 2003; 34 2349 2354 (Pubitemid 37221940)
10. Lib R, DallAsta C, Barbetta L et al. Long-term follow-up study of patients with adrenal incidentalomas. Eur J Endocrinol: 2002; 147 489 494 (Pubitemid 35238144)
11. Liu Y, Mladinov D, Pietrusz J L et al. Glucocorticoid response elements and 11 beta-hydroxysteroid dehydrogenases in the regulation of endothelial nitric oxide synthase expression. Cardiovasc Res: 2009; 81 140 147
12. Mantero F, Terzolo M, Arnaldi G et al. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab: 2000; 85 637 644
13. Mitchell I C, Auchus R J, Juneja K et al. "Subclinical Cushing's syndromeo" is not subclinical: improvement after adrenalectomy in 9 patients. Surgery: 2007; 142 900 905 (Pubitemid 350184118)
14. Nieman L K, Biller B M, Findling J W et al. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab: 2008; 93 1526 1540 (Pubitemid 351656485)
15. Rossi G P, Andreis P G, Colonna S et al. Endothelin-1[1-31]: a novel autocrine-paracrine regulator of human adrenal cortex secretion and growth. J Clin Endocrinol Metab: 2002; 87 322 328 (Pubitemid 34084709)
16. Rossi R, Tauchmanova L, Luciano A et al. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab: 2000; 85 1440 1448 (Pubitemid 32289484)
17. Stamler J, Elliott P, Kesteloot H et al. Inverse relation of dietary protein markers with blood pressure. Findings for 10 020 men and women in the INTERSALT Study. INTERSALT Cooperative Research Group. INTERnational study of SALT and blood pressure. Circulation: 1996; 94 1629 1634 (Pubitemid 26320268)
18. Terzolo M, Bovio S, Pia A et al. Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma. Eur J Endocrinol: 2005; 153 307 315 (Pubitemid 41167489)
19. Terzolo M, Pia A, Al A et al. Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clin Endocrinol Metab: 2002; 87 998 1003 (Pubitemid 36121054)
20. Terzolo M, Reimondo G, Bovio S et al. Subclinical Cushing's syndrome. Pituitary: 2004; 7 217 223 (Pubitemid 43115856)
21. Valli N, Catargi B, Ronci N et al. Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas. Eur J Endocrinol: 2001; 144 401 408 (Pubitemid 32409594)
22. Vassilatou E, Vryonidou A, Michalopoulou S et al. Hormonal activity of adrenal incidentalomas: results from a long-term follow-up study. Clin Endocrinol: 2009; 70 674 679
23. Wood P J, Barth J H, Freedman D B et al. Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome - recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem: 1997; 34 222 229 (Pubitemid 27236924)
24. Xiao D, Huang X, Bae S et al. Cortisol-mediated potentiation of uterine artery contractility: effect of pregnancy. Am J Physiol Heart Circ Physiol: 2002; 283 H238 H246 (Pubitemid 34705345)